The Journal of Organic Chemistry
Article
(100 MHz, CS2/CDCl3 with Cr(acac)3 as relaxation reagent, all 2C
unless indicated) δ 154.88 (1C), 147.95 (1C), 147.75 (1C), 146.12,
146.11, 146.06, 145.89, 145.86, 145.81, 144.84, 144.82, 144.79, 144.56,
144.24, 144.20, 144.15, 144.01, 143.72, 142.46, 142.41, 142.39, 141.98,
141.94, 141.73, 141.55, 141.45, 141.03, 139.62, 139.06, 137.00, 136.61,
135.84 (1C), 128.50, 128.40, 127.97 (1C), 92.39 (1C), 77.77 (1C),
47.86 (1C); FT-IR ν/cm−1 (KBr) 2920, 2848, 1767, 1429, 1385, 1182,
1152, 1084, 1012, 978, 741, 702, 526; UV−vis (CHCl3) λmax/nm (log
ε) 256 (5.09), 319 (4.82), 416 (3.68); MALDI-TOF m/z calcd for
C68H7NO2 [M+] 869.0471, found 869.0443.
90.90 (1C), 75.34 (1C), 64.66 (1C); FT-IR ν/cm−1 (KBr) 2923, 2849,
1790, 1505, 1431, 1263, 1143, 1110, 999, 947, 866, 797, 730, 526;
UV−vis (CHCl3) λmax/nm (log ε) 258 (5.13), 317 (4.82), 418 (3.66);
MALDI-TOF m/z calcd for C62H3NO3 [M+] 809.0107, found
809.0110.
3-(Ethoxylcarbonylmethyl)oxazolidino[4,5:1,2][60]fullerene, 2f.
By following the general procedure, the reaction of C60 (35.9 mg,
0.05 mmol) with 1f (10.4 mg, 0.05 mmol), FeCl3 (1.6 mg, 0.01
mmol), and PhI(O2CCF3)2 (21.7 mg, 0.05 mmol) at 60 °C afforded 2f
(11.9 mg, 27%) and recovered C60 (17.7 mg, 49%): amorphous brown
1
3-Methyloxazolidino[4,5:1,2][60]fullerene, 2b. By following the
general procedure, the reaction of C60 (36.0 mg, 0.05 mmol) with 1b
(6.8 mg, 0.05 mmol), FeCl3 (1.6 mg, 0.01 mmol), and PhI(O2CCF3)2
(21.3 mg, 0.05 mmol) at 60 °C afforded 2b (14.7 mg, 37%) and
solid; H NMR (400 MHz, CS2/CDCl3) δ 4.78 (s, 2H), 4.27 (q, J =
7.0 Hz, 2H), 1.31 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CS2/
DMSO-d6 with Cr(acac)3 as relaxation reagent, all 2C unless
indicated) δ 166.00 (1C), 152.95 (1C), 147.18 (1C), 146.95 (1C),
145.31 (4C), 145.24, 145.09, 145.05, 145.01, 144.10, 143.99, 143.93,
143.66, 143.48, 143.31, 143.25, 143.07, 142.77, 141.61 (4C), 141.53,
141.18, 141.02, 140.86, 140.83, 140.68, 140.30, 138.68, 138.57, 136.43,
136.38, 91.61 (1C), 76.55 (1C), 60.66 (1C), 43.53 (1C), 13.43 (1C);
FT-IR ν/cm−1 (KBr) 2961, 2921, 2852, 1773, 1747, 1414, 1378, 1303,
1
recovered C60 (17.3 mg, 48%): amorphous brown solid; H NMR
(400 MHz, CS2/CDCl3) δ 3.74 (s, 3H); 13C NMR (100 MHz, CS2/
DMSO-d6 with Cr(acac)3 as relaxation reagent, all 2C unless
indicated) δ 152.22 (1C), 147.07 (1C), 146.85 (1C), 145.20 (6C),
145.11, 144.98, 144.96, 143.96, 143.93, 143.90 (4C), 143.41, 143.33,
143.14 (4C), 143.03, 141.55, 141.52, 141.48, 141.09, 140.97, 140.79,
140.76, 140.62, 140.27, 138.67, 138.56, 136.48, 136.11, 90.69 (1C),
77.18 (1C), 28.82 (1C); FT-IR ν/cm−1 (KBr) 2918, 2850, 1767, 1421,
1372, 1266, 1180, 1146, 1033, 1010, 949, 872, 745, 526; UV−vis
(CHCl3) λmax/nm (log ε) 254 (5.01), 317 (4.70), 417 (3.55); MALDI-
TOF m/z calcd for C62H3NO2 [M+] 793.0158, found 793.0160.
3-Butyloxazolidino[4,5:1,2][60]fullerene, 2c. By following the
general procedure, the reaction of C60 (35.9 mg, 0.05 mmol) with
1c (8.7 mg, 0.05 mmol), FeCl3 (1.7 mg, 0.01 mmol), and
PhI(O2CCF3)2 (21.7 mg, 0.05 mmol) at 60 °C afforded 2c (14.8
mg, 35%) and recovered C60 (18.8 mg, 52%): amorphous brown solid;
1H NMR (400 MHz, CS2/CDCl3) δ 4.13 (t, J = 7.6 Hz, 2H), 2.11−
2.03 (m, 2H), 1.59 (sextet, J = 7.4 Hz, 2H), 1.04 (t, J = 7.2 Hz, 3H);
13C NMR (100 MHz, CS2/DMSO-d6 with Cr(acac)3 as relaxation
reagent, all 2C unless indicated) δ 152.85 (1C), 147.24 (1C), 147.05
(1C), 145.37 (6C), 145.17, 145.16 (4C), 144.21, 144.20, 144.10,
144.06, 144.01, 143.60, 143.47, 143.34, 143.06, 141.74, 141.73, 141.70,
144.29, 141.19, 141.02, 140.99, 140.82, 140.43, 138.88, 138.70, 136.27,
136.22, 91.21 (1C), 77.09 (1C), 43.11 (1C), 30.77 (1C), 19.76 (1C),
13.28 (1C); FT-IR ν/cm−1 (KBr) 2952, 2923, 2861, 1767, 1435, 1386,
1259, 1189, 1088, 1058, 1015, 801, 742, 526; UV−vis (CHCl3) λmax
/
nm (log ε) 254 (5.08), 317 (4.79), 416 (3.62); MALDI-TOF m/z
calcd for C65H7NO4 [M+] 865.0370, found 865.0379.
3-(p-Tolyl)oxazolidino[4,5:1,2][60]fullerene, 2g. By following the
general procedure, the reaction of C60 (36.3 mg, 0.05 mmol) with 1g
(20.6 mg, 0.10 mmol), FeCl3 (8.3 mg, 0.05 mmol), and PhI-
(O2CCF3)2 (21.8 mg, 0.05 mmol) at 25 °C afforded 2g (7.0 mg, 16%)
and recovered C60 (29.0 mg, 80%): amorphous brown solid; 1H NMR
(400 MHz, CS2/CDCl3) δ 7.70 (d, J = 8.2 Hz, 2H), 7.37 (d, J = 8.2
Hz, 2H), 2.42 (s, 3H); 13C NMR (100 MHz, CS2/DMSO-d6 with
Cr(acac)3 as relaxation reagent, all 2C unless indicated) δ 152.25 (1C),
147.32 (1C), 147.10 (1C), 145.47 (4C), 145.42, 145.21 (4C), 145.18,
144.30, 144.18, 144.14, 144.10, 143.99, 143.62 (4C), 143.49, 143.42,
141.79, 141.72 (4C), 141.36, 141.26, 141.02, 141.00, 140.79, 140.52,
138.90, 138.58, 138.13 (1C), 136.59, 136.20, 131.94 (1C), 129.37,
128.83, 91.38 (1C), 78.81 (1C), 20.63 (1C); FT-IR ν/cm−1 (KBr)
2946, 2857, 1772, 1510, 1431, 1363, 1232, 1179, 1154, 1087, 1013,
954, 864, 792, 740, 595, 525; UV−vis (CHCl3) λmax/nm (log ε) 257
(5.04), 318 (4.74), 417 (3.57); MALDI-TOF m/z calcd for C68H7NO2
[M+] 869.0471, found 869.0468.
1311, 1185, 1146, 1070, 1013, 963, 744, 526; UV−vis (CHCl3) λmax
/
ASSOCIATED CONTENT
nm (log ε) 255 (5.14), 318 (4.83), 417 (3.81); MALDI-TOF m/z
■
calcd for C65H9NO2 [M+] 835.0628, found 835.0623.
S
* Supporting Information
1H NMR, 13C NMR, and UV-vis spectra of products 2a−g.
This material is available free of charge via the Internet at
3-Isopropyloxazolidino[4,5:1,2][60]fullerene, 2d. By following the
general procedure, the reaction of C60 (36.0 mg, 0.05 mmol) with 1d
(15.9 mg, 0.10 mmol), FeCl3 (1.6 mg, 0.01 mmol), and PhI-
(O2CCF3)2 (21.5 mg, 0.05 mmol) at 40 °C afforded 2d (9.8 mg, 24%)
and recovered C60 (21.7 mg, 60%): amorphous brown solid; 1H NMR
(400 MHz, CS2/CDCl3) δ 4.65 (septet, J = 6.8 Hz, 1H), 1.85 (d, J =
6.8 Hz, 6H); 13C NMR (100 MHz, CS2/DMSO-d6 with Cr(acac)3 as
relaxation reagent, all 2C unless indicated) δ 151.43 (1C), 147.18
(1C), 147.01 (1C), 145.36, 145.34, 145.31, 145.15, 145.12 (4C),
144.34, 144.21, 144.04, 144.02, 143.79, 143.61, 143.34, 143.29, 143.16,
141.71 (4C), 141.63, 141.29, 141.14, 140.99, 140.91, 140.75, 140.41,
138.80, 138.64, 136.32, 136.14, 91.12 (1C), 77.33 (1C), 46.83 (1C),
19.36; FT-IR ν/cm−1 (KBr) 2960, 2922, 2853, 1762, 1505, 1455,
1418, 1374, 1316, 1262, 1218, 1095, 1013, 958, 803, 744, 570, 526;
UV−vis (CHCl3) λmax/nm (log ε) 259 (5.18), 318 (4.85), 416 (3.71);
MALDI-TOF m/z calcd for C64H7NO2 [M+] 821.0471, found
821.0443.
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We are grateful for financial support from the National Natural
Science Foundation of China (Grant 21132007), Specialized
Research Fund for the Doctoral Program of Higher Education
(Grant 20123402130011), and Open Project of State Key
Laboratory Cultivation Base for Nonmetal Composites and
Functional Materials (Grant 11zxfk15).
3-Methoxyloxazolidino[4,5:1,2][60]fullerene, 2e. By following the
general procedure, the reaction of C60 (36.7 mg, 0.05 mmol) with 1e
(7.7 mg, 0.05 mmol), FeCl3 (1.5 mg, 0.01 mmol), and PhI(O2CCF3)2
(22.0 mg, 0.05 mmol) at 25 °C afforded 2e (10.9 mg, 26%) and
1
REFERENCES
recovered C60 (21.2 mg, 58%): amorphous brown solid; H NMR
■
(400 MHz, CS2/CDCl3) δ 4.43 (s, 3H); 13C NMR (100 MHz, CS2/
DMSO-d6 with Cr(acac)3 as relaxation reagent, all 2C unless
indicated) δ 150.52 (1C), 147.15 (1C), 146.84 (1C), 145.31,
145.28, 145.22, 145.11, 145.02 (4C), 143.98, 143.97, 143.89, 143.53,
143.32, 143.26, 143.25, 143.10, 143.01, 141.60, 141.57, 141.53, 141.11,
141.07, 140.91, 140.83, 140.73, 140.16, 138.83, 138.70, 136.49, 135.96,
(1) For selected reviews, see: (a) Nakamura, E.; Isobe, H. Acc. Chem.
Res. 2003, 36, 807. (b) Guldi, D. M.; Illescas, B. M.; Atienza, C. M.;
Wielopolski, M.; Martín, N. Chem. Soc. Rev. 2009, 38, 1587.
(c) Vougioukalakis, G. C.; Roubelakis, M. M.; Orfanopoulos, M.
Chem. Soc. Rev. 2010, 39, 817. (d) Zhu, S.-E; Li, F.; Wang, G.-W.
Chem. Soc. Rev. 2013, 42, 7535.
D
dx.doi.org/10.1021/jo402354w | J. Org. Chem. XXXX, XXX, XXX−XXX